4. November 2023
𝗛𝗕𝗢𝗫 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗿𝗲𝗰𝗲𝗶𝘃𝗲 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗼𝘂𝘀 𝗘𝗜𝗖 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗳𝘂𝗻𝗱𝗶𝗻𝗴
HBOX Therapies was selected as one of the most promising start-ups in Europe, thanks to our innovative product and robust business plan. This means we will receive a grant of €2.5M and a potential follow-on investment to further advance and commercialize our medical device MiRA. We are very proud and grateful for this achievement. We will continue working hard to make our vision a reality and to improve clinical outcomes.
About EIC Accelerator:
The EIC Accelerator is the cornerstone of the Horizon Europe funding programme (2021-2027) by the European Commission and the European Innovation Council (EIC). It is designed for small and medium-sized enterprises, mid-cap companies and individuals who need financial support to bring their novel ideas, technologies and products to the market.
MiRA (Miniatuarized Respiratory Assist) is expected to become the first alternative to invasive mechanical ventilation for patients suffering from acute lung failure. MiRA aims to reduce complication rates and improve outcomes, offering a new treatment regime for millions of patients annually.